NCT06363877

Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections

Name: Clinical Trial NCT06363877
Creator: Loma Linda University
Keywords: Surgical Site Infection, Povidone-Iodine, Phase 3, drug, clinical trial, United States of America

Wound Irrigation and Peritoneal Lavage With Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections

Loma Linda University·Phase 3·ClinicalTrials.gov·drugNot yet recruiting

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Surgical Site Infection
Drug/Device/Intervention: Povidone-Iodine
Study type: Interventional
Intervention type: drug

Sponsor & location

Primary sponsor: Loma Linda University
Location: Loma Linda, United States of America

Timeline & enrollment

Phase: Phase 3
Start date: May 01, 2024
End date: Nov 01, 2025
Enrollment: 1100 participants

Primary outcome

Surgical Site Infection

Summary

This is a multicenter randomized controlled trial of 1100 patients to evaluate the superiority of combined intraoperative wound irrigation with intraoperative peritoneal lavage with dilute aqueous povidone-iodine compared to normal saline in male and female patients between the ages of 18 and 80 years old undergoing emergency laparotomies with Centers for Disease Control (CDC) class 2 and 3 wounds.

ICD-10 classifications

Infection following a procedure, not elsewhere classifiedBacterial infection of unspecified siteOther bacterial infections of unspecified siteInfection of obstetric surgical woundOther specified local infections of skin and subcutaneous tissue

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06363877
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06363877 through Pure Global AI's free database. This Phase 3 trial is sponsored by Loma Linda University and is currently Not yet recruiting. The study focuses on Surgical Site Infection. Target enrollment is 1100 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.